In a filing, Guardant Health Inc revealed its Director Tariq Musa unloaded Company’s shares for reported $6453.0 on Sep 17 ’25. In the deal valued at $55.63 per share,116 shares were sold. As a result of this transaction, Tariq Musa now holds 7,591 shares worth roughly $0.45 million.
Then, POTTER MYRTLE S sold 26 shares, generating $1,446 in total proceeds. Upon selling the shares at $55.63, the Director now owns 18,281 shares.
Before that, POTTER MYRTLE S bought 26 shares. Guardant Health Inc shares valued at $1,446 were divested by the Director at a price of $55.62 per share.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in early April with a ‘”an Outperform”‘ rating. Barclays began covering GH with “an Overweight” recommendation on January 23, 2025. Guggenheim revised its rating on June 28, 2024. It rated GH as “a Buy” which previously was an “a Neutral”.
Price Performance Review of GH
On Tuesday, Guardant Health Inc [NASDAQ:GH] saw its stock fall -0.10% to $59.72. Over the last five days, the stock has gained 7.80%. Guardant Health Inc shares have risen nearly 135.21% since the year began. Nevertheless, the stocks have risen 95.48% over the past one year. While a 52-week high of $68.00 was reached on 09/02/25, a 52-week low of $20.14 was recorded on 01/02/25.
Levels Of Support And Resistance For GH Stock
The 24-hour chart illustrates a support level at 58.83, which if violated will result in even more drops to 57.94. On the upside, there is a resistance level at 61.15. A further resistance level may holdings at 62.57.
How much short interest is there in Guardant Health Inc?
A steep rise in short interest was recorded in Guardant Health Inc stocks on 2025-08-29, dropping by -1.37 million shares to a total of 8.02 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 9.4 million shares. There was a decline of -17.11%, which implies that there is a negative sentiment for the stock.
